A Guide to Support Medication Review in Older People

This is a guide to help pharmacists assess and adjust medicines for older people, including guidance on stopping or changing medicines in older people and starting medicines in older people.


A Guide to Support Medication Review in Older People - cover page
Category
Other
Document type
Other
Language
English
Pages
25
File format
PDF
File size
293 KB
Published
03 November, 2023
Updated
03 November, 2023
MD5 checksum
4DD1A7123B331B418B57AEFB270173D4

About this manual

This document, titled 'A Guide to Support Medication Review in Older People' (3rd Edition, May 2020), was developed by the Northern Ireland Pharmacists working with Older People (NIPOP) Network. It is intended to support healthcare professionals when carrying out comprehensive reviews of the appropriateness of medicines prescribed for older people, particularly in the context of polypharmacy.

The guide is not a prescriptive document and should be used in conjunction with other relevant up-to-date resources such as the NI Formulary, NICE Clinical Guidelines, and the British National Formulary (BNF). It provides practical advice on stopping or altering specific medicines based on clinical contexts, risks (such as falls, renal impairment, and anticholinergic burden), and evidence-based criteria like STOPP/START.

What's inside

  • Introduction
  • How to use this guide
  • Medicines which may be appropriate to stop or alter
  • Medicines which may be appropriate to start
  • Gastro-intestinal system
  • Cardiovascular System
  • Appendix 1: NIPOP Steering Group
  • Appendix 2: References
  • Appendix 3: Abbreviations
  • Appendix 4: QT-interval and CYP3A4 inhibitors

Frequently asked questions

What is the purpose of this guide?

It supports healthcare professionals when carrying out comprehensive reviews of the appropriateness of medicines prescribed for older people.

What is the recommended duration for using Proton Pump Inhibitors (PPIs) for uncomplicated peptic ulcer disease?

For uncomplicated peptic ulcer disease, PPIs should be used at full therapeutic dosage for > 8 weeks.

Download PDF (293 KB)

Also Manuals